Sjögren's Syndrome Clinical Trial
Official title:
Using the DNA Exome Sequencing Tools to Explore the Association Among Gene Sequence, TCM Pattern, TCM Tongue Diagnosis and TCM Pulse Diagnosis for Sjögren's Syndrome
Verified date | May 2019 |
Source | Taipei Veterans General Hospital, Taiwan |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
To explore the association among gene, TCM pattern, TCM tongue diagnosis and TCM pulse diagnosis with the DNA Exome sequencing tools for Sjögren's syndrome
Status | Active, not recruiting |
Enrollment | 40 |
Est. completion date | December 31, 2019 |
Est. primary completion date | May 15, 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 20 Years to 75 Years |
Eligibility |
Sjögren's syndrome Inclusion Criteria: - (1) primary or secondary SS - (2) aged between 20 and 75 years - (3) fulfilled the 2002 American-European Consensus Criteria for SS (AECG) - (4) had no abnormal findings of immune, liver, kidney, or blood function evaluations. Exclusion Criteria: - (1)a history of alcohol abuse, diabetes mellitus, or major life-threatening condition - (2) pregnancy or breastfeeding - (3) steroid pulse therapy within three months prior to the commencement of our study. Health Subjects Inclusion Criteria: - (1) aged 20 and 75 years - (2) had no chronic inflammatory illness. Exclusion Criteria: - (1) a history of alcohol abuse, diabetes mellitus, or major life-threatening condition - (2) pregnancy or breastfeeding - (3) abnormal findings of immune, liver, kidney, or blood function evaluations - (4) total sleeping time insufficiency less than 6 hours before one day of enrollment - (5) ever took the conventional medicine or hormone within one month - (6) ever encountered the acute illness, allergy reaction, immune, or rheumatic disease within one month. |
Country | Name | City | State |
---|---|---|---|
Taiwan | Ching-Mao Chang | Taipei | Taiwan (r.o.c.) |
Lead Sponsor | Collaborator |
---|---|
Taipei Veterans General Hospital, Taiwan |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Immunity-related gene expression | To evaluate the immunity-related gene expression for the Sjögren's syndrome and healthy control. DNA exome combine the GATK (Genome Analysis Toolkit) is a tool for detecting the ratio of immunity-related gene expression. |
One year | |
Primary | TCM pattern | To evaluate the difference of TCM pattern between Sjögren's syndrome and healthy control. TCM pattern is a tool for detecting the constitution. |
One year | |
Primary | TCM tongue diagnosis | To evaluate the difference of TCM tongue diagnosis between Sjögren's syndrome and healthy control. TCM tongue diagnosis is a tool for detecting tongue expression. |
One year | |
Primary | TCM pulse diagnosis | To evaluate the difference of TCM pulse diagnosis between Sjögren's syndrome and healthy control. TCM pulse diagnosis is a tool for detecting pulse of radial artery. |
One year | |
Primary | Heart rate variability (HRV) | To evaluate the difference of Heart rate variability (HRV) between Sjögren's syndrome and healthy control. HRV is a tool for detecting the ratio between High-frequency (HF) activity and low-frequency (LF) activity. |
One year | |
Primary | Immunity-related proteomics expression | To evaluate the proteomics for the Sjögren's syndrome and healthy control. Proteomics is a tool for detecting the ratio of immunity-related proteomics expression. |
One year | |
Primary | Immunity-related microbiome expression | To evaluate the oral microbiome for the Sjögren's syndrome and healthy control. Oral microbiome is a tool for detecting the ratio of immunity-related microbiome expression. |
One year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05946941 -
A Study to Evaluate the Efficacy and Safety of Deucravacitinib in Adults With Active Sjögren's Syndrome
|
Phase 3 | |
Completed |
NCT05633524 -
HRR as a Novel Biomarker in Sjögren's Syndrome
|
||
Terminated |
NCT02843659 -
Proof of Concept Study to Evaluate the Efficacy and Safety of BMS-931699 (Lulizumab) or BMS-986142 in Primary Sjögren's Syndrome
|
Phase 2 | |
Completed |
NCT04129164 -
A Study to Evaluate the Efficacy and Safety of VIB4920 in Participants With Sjögren's Syndrome
|
Phase 2 | |
Completed |
NCT04798911 -
SS-INQ Information Needs Questionnaire in Sjögren's Syndrome
|
||
Recruiting |
NCT05605665 -
Low-dose Interleukin-2 and Rapamycin on sjögren's Syndrome
|
Phase 1/Phase 2 | |
Completed |
NCT02833311 -
e-Mobile Tablet for People With Chronic Conditions
|
N/A | |
Completed |
NCT04572841 -
Safety, Tolerability, Pharmacokinetics, and Therapeutic Efficacy of SAR441344 in Primary Sjögren's Syndrome (pSjS)
|
Phase 2 | |
Completed |
NCT04111341 -
A Clinical Trial to Evaluate the Safety and Efficacy of Traditional Chinese Medicine in Sjögren's Syndrome.
|
Phase 2 | |
Recruiting |
NCT03060005 -
Is Sjögren's Syndrome Associated With Meibomian Gland Dysfunction ?
|
N/A | |
Terminated |
NCT01316770 -
Dexamethasone Irrigation of the Parotid Glands in Primary Sjögren's Syndrome Subjects
|
Phase 2 | |
Completed |
NCT02422407 -
A Longitudinal, Observational Biomarker Study in Participants With Primary Sjogren's Syndrome
|
N/A | |
Completed |
NCT01160666 -
Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT02849093 -
Optical Coherence Tomography of Ocular Structures in Epiphora and Dry Eye Syndrome.
|
N/A | |
Active, not recruiting |
NCT02112019 -
Endoscopic Treatment of Salivary Glands Affected by Sjögren's Syndrome
|
N/A | |
Recruiting |
NCT03983408 -
Impact of Korean Red Ginseng on Fatigue in Patients With Rheumatic Disease
|
N/A | |
Completed |
NCT00873496 -
Effects of Hydroxychloroquine on Oral Complaints of Sjögren Patients
|
N/A | |
Completed |
NCT05680064 -
The Effect of Chewing Gum, Exercises of the Tongue, Lip, Jaw on Salivation, Xerostomia, Dysphagia in Sjögren's Syndrome
|
N/A | |
Recruiting |
NCT02855658 -
Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome
|
Phase 2 | |
Recruiting |
NCT02110446 -
Evaluation of the Efficacy and the Mechanism of Chinese Herbal Formula SS-1 for Sjögren's Syndrome
|
Phase 2 |